Influence of a modified preservation solution in kidney transplantation: A comparative experimental study in a porcine model

Asian Journal of Surgery

Volumn 40, Issue 2, 2017, Pages 106-115

  Golriz, Mohammad ^a   Fonouni, Hamidreza ^a   Kuttymuratov, Gani ^a   Esmaeilzadeh, Majid ^a   Rad, Morva Tahmasbi ^a   Jarahian, Parvin ^a   Longerich, Thomas ^a   Faridar, Alireza ^a   Abbasi, Sepehr ^a   Mehrabi, Arianeb ^a   Gebhard, Marta M ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

ischemia reperfusion injury; kidney transplantation; preservation solution

Indexed keywords

ADENOSINE; ALLOPURINOL; GLUCOSE; GLUTATHIONE; HTK SOLUTION; INSULIN; MANNITOL; POTASSIUM CHLORIDE; PRESERVATION SOLUTION; PROCAINE; RAFFINOSE; UNIVERSITY OF WISCONSIN-LACTOBIONATE SOLUTION;

ANIMAL; CHEMISTRY; COMPARATIVE STUDY; DISEASE MODEL; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; KIDNEY TRANSPLANTATION; MALE; NEEDLE BIOPSY; ORGAN PRESERVATION; PIG; PROCEDURES; RANDOMIZATION; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TREATMENT OUTCOME;

ADENOSINE; ALLOPURINOL; ANIMALS; BIOPSY, NEEDLE; DISEASE MODELS, ANIMAL; FEMALE; GLUCOSE; GLUTATHIONE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; INSULIN; KIDNEY TRANSPLANTATION; MALE; MANNITOL; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; POTASSIUM CHLORIDE; PROCAINE; RAFFINOSE; RANDOM ALLOCATION; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; SWINE; TREATMENT OUTCOME;

EID: 84940704590     PISSN: 10159584     EISSN: 02193108     Source Type: Journal    
DOI: 10.1016/j.asjsur.2015.07.001     Document Type: Article

References (62)

1. 1 Belzer, F.O., Southard, J.H., Principles of solid-organ preservation by cold storage. Transplantation 45 (1988), 673–676.
2. 2 de Groot, H., Rauen, U., Ischemia-reperfusion injury: processes in pathogenetic networks: a review. Transplant Proc 39 (2007), 481–484.
3. 3 Parsons, R.F., Guarrera, J.V., Preservation solutions for static cold storage of abdominal allografts: which is best?. Curr Opin Organ Transplant 19 (2014), 100–107.
4. 4 Gubernatis, G., Pichlmayr, R., Lamesch, P., et al. HTK-solution (Bretschneider) for human liver transplantation. First clinical experiences. Langenbecks Arch Chir 375 (1990), 66–70.
5. 5 den Butter, G., Saunder, A., Marsh, D.C., Belzer, F.O., Southard, J.H., Comparison of solutions for preservation of the rabbit liver as tested by isolated perfusion. Transpl Int 8 (1995), 466–471.
6. 6 Aminalai, A., Kehrer, G., Grossmann, F., Richter, J., Bretschneider, H.J., Morphological investigation of the porcine liver directly following preservation with Euro-Collins, University of Wisconsin and Bretschneider's HTK solution. Langenbecks Arch Chir 377 (1992), 81–88.
7. 7 Roels, L., Coosemans, W., Donck, J., et al. Inferior outcome of cadaveric kidneys preserved for more than 24 hr in histidine-tryptophan-ketoglutarate solution. Leuven Collaborative Group for Transplantation. Transplantation 66 (1998), 1660–1664.
8. 8 Schneeberger, H., Schleibner, S., Illner, W.D., Messmer, K., Land, W., The impact of free radical-mediated reperfusion injury on acute and chronic rejection events following cadaveric renal transplantation. Clin Transpl, 1993, 219–232.
9. 9 Goggins, W.C., Pascual, M.A., Powelson, J.A., et al. A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients. Transplantation 76 (2003), 798–802.
10. 10 Beiras-Fernandez, A., Thein, E., Chappel, D., et al. Polyclonal anti-thymocyte globulins influence apoptosis in reperfused tissues after ischaemia in a non-human primate model. Transpl Int 17 (2004), 453–457.
11. 11 Bogetti, D., Sankary, H.N., Jarzembowski, T.M., et al. Thymoglobulin induction protects liver allografts from ischemia/reperfusion injury. Clin Transpl 19 (2005), 507–511.
12. 12 Akoh, J.A., Kidney donation after cardiac death. World J Nephrol 1 (2012), 79–91.
13. 13 Zatschler, B., Dieterich, P., Muller, B., Kasper, M., Rauen, U., Deussen, A., Improved vessel preservation after 4 days of cold storage: experimental study in rat arteries. J Vasc Surg 50 (2009), 397–406.
14. 14 Koch, A., Loganathan, S., Radovits, T., Sack, F.U., Karck, M., Szabo, G.B., Deferoxamine, the newly developed iron chelator LK-614 and N-alpha-acetyl-histidine in myocardial protection. Interact Cardiovasc Thorac Surg 10 (2010), 181–184.
15. 15 Bahde, R., Palmes, D., Gemsa, O., et al. Attenuated cold storage injury of rat livers using a modified HTK solution. J Surg Res 146 (2008), 49–56.
16. 16 Lesnefsky, E.J., Allen, K.G., Carrea, F.P., Horwitz, L.D., Iron-catalyzed reactions cause lipid peroxidation in the intact heart. J Mol Cell Cardiol 24 (1992), 1031–1038.
17. 17 Rauen, U., de Groot, H., Inherent toxicity of organ preservation solutions to cultured hepatocytes. Cryobiology 56 (2008), 88–92.
18. 18 Schroder, C., Heintz, A., Pexa, A., Rauen, U., Deussen, A., Preclinical evaluation of coronary vascular function after cardioplegia with HTK and different antioxidant additives. Eur J Cardiothorac Surg 31 (2007), 821–826.
19. 19 White, B.C., Krause, G.S., Aust, S.D., Eyster, G.E., Postischemic tissue injury by iron-mediated free radical lipid peroxidation. Ann Emerg Med 14 (1985), 804–809.
20. 20 Tapuria, N., Kumar, Y., Habib, M.M., Abu Amara, M., Seifalian, A.M., Davidson, B.R., Remote ischemic preconditioning: a novel protective method from ischemia reperfusion injury–a review. J Surg Res 150 (2008), 304–330.
21. 21 Kloppel, K., Gerlach, J., Neuhaus, P., The electrolyte composition of liver preservation solutions for hepatocytes in a model of in vitro preservation and reoxygenation. Langenbecks Arch Chir 379 (1994), 210–217.
22. 22 Umeshita, K., Monden, M., Fujimori, T., et al. Extracellular calcium protects cultured rat hepatocytes from injury caused by hypothermic preservation. Cryobiology 25 (1988), 102–109.
23. 23 Gebhard, M.M., Gross, W., Schäfer, M., Organprotektion: Neue aspekte. Chirurgische Forschung, 2005, 317–324 [in German].
24. 24 Zonta, S., Lovisetto, F., Lorenzo, C., et al. Uretero-neocystostomy in a swine model of kidney transplantation: a new technique. J Surg Res 124 (2005), 250–255.
25. 25 Wu, A., Yamada, K., Ierino, F.L., Vagefi, P.A., Sachs, D.H., Regulatory mechanism of peripheral tolerance: in vitro evidence for dominant suppression of host responses during the maintenance phase of tolerance to renal allografts in miniature swine. Transpl Immunol 11 (2003), 367–374.
26. 26 Golriz, M., Fonouni, H., Nickkholgh, A., Hafezi, M., Garoussi, C., Mehrabi, A., Pig kidney transplantation: an up-to-date guideline. Eur Surg Res 49 (2012), 121–129.
27. 27 Golriz, M., Hafezi, M., Garoussi, C., et al. Do we need animal hands-on courses for transplantation surgery?. Clin Transpl 27 (2013), S6–15.
28. 28 Booster, M.H., van der Vusse, G.J., Wijnen, R.M., Yin, M., Stubenitsky, B.M., Kootstra, G., University of Wisconsin solution is superior to histidine tryptophan ketoglutarate for preservation of ischemically damaged kidneys. Transplantation 58 (1994), 979–984.
29. 29 Bretschneider, H.J., Helmchen, U., Kehrer, G., Kidney protection. Klin Wochenschr 66 (1988), 817–827.
30. 30 Busing, M., Hopt, U.T., Schareck, W., Ernst, M., Morgenroth, K., Ultrastructural changes of different preserved human kidney allografts before and after reperfusion. Transplant Proc 22 (1990), 448–449.
31. 31 Orak, J.K., Singh, A.K., Rajagopalan, P.R., Singh, I., Morphological analysis of mitochondrial integrity in prolonged cold renal ischemia utilizing Euro-Collins versus University of Wisconsin preservation solution in a whole organ model. Transplant Proc 26 (1994), 122–125.
32. 32 Kwon, O., Nelson, W.J., Sibley, R., et al. Backleak, tight junctions, and cell- cell adhesion in postischemic injury to the renal allograft. J Clin Invest 101 (1998), 2054–2064.
33. 33 Franquesa, M., Flaquer, M., Cruzado, J.M., Grinyo, J.M., Kidney regeneration and repair after transplantation. Curr Opin Organ Transplant 18 (2013), 191–196.
34. 34 de Boer, J., De Meester, J., Smits, J.M., et al. Eurotransplant randomized multicenter kidney graft preservation study comparing HTK with UW and Euro-Collins. Transpl Int 12 (1999), 447–453.
35. 35 Erhard, J., Lange, R., Scherer, R., et al. Comparison of histidine-tryptophan-ketoglutarate (HTK) solution versus University of Wisconsin (UW) solution for organ preservation in human liver transplantation. A prospective, randomized study. Transpl Int 7 (1994), 177–181.
36. 36 Feng, L., Zhao, N., Yao, X., et al. Histidine-tryptophan-ketoglutarate solution vs. University of Wisconsin solution for liver transplantation: a systematic review. Liver Transpl 13 (2007), 1125–1136.
37. 37 Fridell, J.A., Mangus, R.S., Tector, A.J., Clinical experience with histidine-tryptophan-ketoglutarate solution in abdominal organ preservation: a review of recent literature. Clin Transpl 23 (2009), 305–312.
38. 38 Mangus, R.S., Tector, A.J., Fridell, J.A., Kazimi, M., Hollinger, E., Vianna, R.M., Comparison of histidine-tryptophan-ketoglutarate solution and University of Wisconsin solution in intestinal and multivisceral transplantation. Transplantation 86 (2008), 298–302.
39. 39 Montalti, R., Nardo, B., Capocasale, E., et al. Kidney transplantation from elderly donors: a prospective randomized study comparing celsior and UW solutions. Transplant Proc 37 (2005), 2454–2455.
40. 40 Kerkweg, U., Jacob, M., De Groot, H., Mannherz, H.G., Rauen, U., Cold-induced apoptosis of rat liver endothelial cells: contribution of mitochondrial alterations. Transplantation 76 (2003), 501–508.
41. 41 Wu, S., Wohlschlaeger, J., de Groot, H., Rauen, U., Evaluation of a modified HTK solution containing the new iron chelator LK 614 in an isolated rat liver perfusion model. J Invest Surg 22 (2009), 340–347.
42. 42 Rauen, U., Klempt, S., de Groot, H., Histidine-induced injury to cultured liver cells, effects of histidine derivatives and of iron chelators. Cell Mol Life Sci 64 (2007), 192–205.
43. 43 Rauen, U., Petrat, F., Sustmann, R., de Groot, H., Iron-induced mitochondrial permeability transition in cultured hepatocytes. J Hepatol 40 (2004), 607–615.
44. 44 Koch, A., Radovits, T., Loganathan, S., Sack, F.U., Karck, M., Szabo, G.B., Myocardial protection with the use of L-arginine and N-alpha-acetyl-histidine. Transplant Proc 41 (2009), 2592–2594.
45. 45 Loganathan, S., Radovits, T., Hirschberg, K., et al. Effects of Custodiol-N, a novel organ preservation solution, on ischemia/reperfusion injury. J Thorac Cardiovasc Surg 139 (2010), 1048–1056.
46. 46 Radovits, T., Lin, L.N., Zotkina, J., et al. Endothelial dysfunction after long-term cold storage in HTK organ preservation solutions: effects of iron chelators and N-alpha-acetyl-L-histidine. J Heart Lung Transplant 27 (2008), 208–216.
47. 47 Wu, K., Turk, T.R., Rauen, U., et al. Prolonged cold storage using a new histidine-tryptophan-ketoglutarate-based preservation solution in isogeneic cardiac mouse grafts. Eur Heart J 32 (2011), 509–516.
48. 48 Garbe, S., Zatschler, B., Muller, B., et al. Preservation of human artery function following prolonged cold storage with a new solution. J Vasc Surg 53 (2011), 1063–1070.
49. 49 Menger, M.D., Vollmar, B., Pathomechanisms of ischemia-reperfusion injury as the basis for novel preventive strategies: is it time for the introduction of pleiotropic compounds?. Transplant Proc 39 (2007), 485–488.
50. 50 Rauen, U., Li, T., Sustmann, R., De Groot, H., Protection against iron- and hydrogen peroxide-dependent cell injuries by a novel synthetic iron catalase mimic and its precursor, the iron-free ligand. Free Radic Biol Med 37 (2004), 1369–1383.
51. 51 Arosio, P., Levi, S., Cytosolic and mitochondrial ferritins in the regulation of cellular iron homeostasis and oxidative damage. Biochim Biophys Acta 1800 (2010), 783–792.
52. 52 Nowak, K., Hanusch, C., Nicksch, K., et al. Pre-ischaemic conditioning of the pulmonary endothelium by immunotargeting of catalase via angiotensin-converting-enzyme antibodies. Eur J Cardiothorac Surg 37 (2010), 859–863.
53. 53 Gutteridge, J.M., Does redox regulation of cell function explain why antioxidants perform so poorly as therapeutic agents?. Redox Rep 4 (1999), 129–131.
54. 54 Aruoma, O.I., Grootveld, M., Bahorun, T., Free radicals in biology and medicine: from inflammation to biotechnology. Biofactors 27 (2006), 1–3.
55. 55 Chua, A.C., Graham, R.M., Trinder, D., Olynyk, J.K., The regulation of cellular iron metabolism. Crit Rev Clin Lab Sci 44 (2007), 413–459.
56. 56 Gebhard, M.M., Pathophysiology of global ischemia of the heart. Z Kardiol 76 (1987), S115–129.
57. 57 Gebhard, M.M., Bretschneider, H.J., Gersing, E., Preusse, C.J., Schnabel, P.A., Ulbricht, L.J., Calcium-free cardioplegia–pro. Eur Heart J 4 (1983), S151–160.
58. 58 Gebhard, M.M., Preusse, C.J., Schnabel, P.A., Bretschneider, H.J., Different effects of cardioplegic solution HTK during single or intermittent administration. Thorac Cardiovasc Surg 32 (1984), 271–276.
59. 59 Gebhard, M.M., Gersing, E., Brockhoff, C.J., Schnabel, P.A., Bretschneider, H.J., Impedance spectroscopy: a method for surveillance of ischemia tolerance of the heart. Thorac Cardiovasc Surg 35 (1987), 26–32.
60. 60 Halliwell, B., Biochemistry of oxidative stress. Biochem Soc Trans 35 (2007), 1147–1150.
61. 61 Long, L.H., Hoi, A., Halliwell, B., Instability of, and generation of hydrogen peroxide by, phenolic compounds in cell culture media. Arch Biochem Biophys 501 (2010), 162–169.
62. 62 Radovits, T., Zotkina, J., Lin, L.N., Karck, M., Szabo, G., Endothelial dysfunction after hypoxia-reoxygenation: do in vitro models work?. Vascul Pharmacol 51 (2009), 37–43.